Know Cancer

or
forgot password

An Open-label, Single-arm. Multi-center Phase 2 Trial With Ofatumumab in Patients With Relapsed/Progressive Diffuse Large B-Cell Lymphoma (DLBCL) Ineligible for Transplant or Relapse/Progression After Autologous Transplant


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Lymphoma, Large-Cell, Diffuse

Thank you

Trial Information

An Open-label, Single-arm. Multi-center Phase 2 Trial With Ofatumumab in Patients With Relapsed/Progressive Diffuse Large B-Cell Lymphoma (DLBCL) Ineligible for Transplant or Relapse/Progression After Autologous Transplant


Inclusion Criteria:



Patients with DLBCL

- and relapse after complete remission or disease progression after partial remission
who are ineligible for autologous stem cell transplantation

- and relapse after complete remission or disease progression after partial remission
following autologous stem cell transplantation.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Number of Participants With Objective Response

Outcome Description:

Objective response of ofatumumab treatment was assessed according to the "revised response criteria for malignant lymphoma." Participants with objective response were defined as responders with complete remission (CR) or partial remission (PR) of disease. CR is defined as the disappearance of all evidence of disease, and PR is defined as the regression of measurable disease with no new sites of disease.

Outcome Time Frame:

6-month period from start of treatment (up to Week 24). Participants were followed up for an average of 2.8 months.

Safety Issue:

No

Principal Investigator

GSK Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

GlaxoSmithKline

Authority:

United States: Food and Drug Administration

Study ID:

111776

NCT ID:

NCT00622388

Start Date:

December 2007

Completion Date:

August 2014

Related Keywords:

  • Lymphoma, Large-Cell, Diffuse
  • Lymphoma
  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse

Name

Location